Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers

ISSN： 0946-2716

Source： Journal of Molecular Medicine, Vol.82, Iss.4, 2004-04, pp. : 223-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Whether lithium inhibits glycogen synthase kinase (GSK)‐3β activity in vivo in humans is still an open question

BIPOLAR DISORDERS (ELECTRONIC), Vol. 18, Iss. 5, 2016-08 ,pp. : 464-467

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Significance of Inactivated Glycogen Synthase Kinase 3β in HPV‐Associated Cervical Cancer: Relationship with Wnt/β‐Catenin Pathway Activation

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (ELECTRONIC), Vol. 73, Iss. 5, 2015-05 ,pp. : 460-478

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection of Active Fraction of Glycogen Synthase Kinase 3β in Cancer Cells by Nonradioisotopic in vitro Kinase Assay

Oncology, Vol. 71, Iss. 3-4, 2007-07 ,pp. : 297-305

Karger

Access to resources Recommend Favorite

A 2D image-based approach for modelling some glycogen synthase kinase 3 inhibitors

By Freitas Matheus

Medicinal Chemistry Research, Vol. 16, Iss. 7-9, 2007-12 ,pp. : 461-467

Springer Publishing Company

Access to resources Recommend Favorite

Glycogen synthase kinase-3β inhibition attenuates the development of ischaemia/reperfusion injury of the gut

By Cuzzocrea Salvatore Mazzon Emanuela Esposito Emanuela Muià Carmelo Abdelrahman Maha Paola Rosanna Crisafulli Concetta Bramanti Placido Thiemermann Christoph

Intensive Care Medicine, Vol. 33, Iss. 5, 2007-05 ,pp. : 880-893

Springer Publishing Company

Access to resources Recommend Favorite